Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 2

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Esophageal Cancer

World J Gastroenterol. Apr 15, 2002; 8(2): 203-207
Published online Apr 15, 2002. doi: 10.3748/wjg.v8.i2.203

Table 1 egr-1 transcription and expression in HCC tissue and its normal counterparts

Tissue	n	mRNA (%)	n	Protein (%)
Normal liver	8	0 (0.0)	2	0 (0.0)
Hepatic paracancerous tissue	22	21 (95.5)	5	4 (80.0)
Liver carcinoma	24	6 (25.0)^a	3	0 (0.0)^b

^aP = 0.000,

^bP = 0.143, vs hepatic paracancerous tissue

Citation: Hao MW, Liang YR, Liu YF, Liu L, Wu MY, Yang HX. Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines. World J Gastroenterol 2002; 8(2): 203-207
URL: https://www.wjgnet.com/1007-9327/full/v8/i2/203.htm
DOI: https://dx.doi.org/10.3748/wjg.v8.i2.203

Hao MW, Liang YR, Liu YF, Liu L, Wu MY, Yang HX. Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines. World J Gastroenterol 2002; 8(2): 203-207 [PMID: 11925592 DOI: 10.3748/wjg.v8.i2.203]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.